These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 10523580)

  • 1. Predicting susceptibility of Streptococcus pneumoniae to ceftriaxone and cefotaxime by cefuroxime and ceftizoxime disk diffusion testing.
    Williams-Bouyer N; Hernandez A; Reisner BS
    J Clin Microbiol; 1999 Nov; 37(11):3707-10. PubMed ID: 10523580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for cephalosporin-resistant Streptococcus pneumoniae with the Kirby-Bauer disk susceptibility test.
    Friedland IR; Shelton S; McCracken GH
    J Clin Microbiol; 1993 Jun; 31(6):1619-21. PubMed ID: 8315005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of an oxacillin disk screening test for detection of penicillin- and ceftriaxone-resistant pneumococci.
    Jetté LP; Sinave C
    J Clin Microbiol; 1999 Apr; 37(4):1178-81. PubMed ID: 10074547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of ceftizoxime, ceftazidime, cefuroxime, ceftriaxone, cefotaxime, and penicillin against Streptococcus pneumoniae as determined by three quantitative methods.
    Barry AL; Brown SD; Fuchs PC
    Eur J Clin Microbiol Infect Dis; 1996 Apr; 15(4):344-6. PubMed ID: 8781889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro killing of penicillin-susceptible, -intermediate, and -resistant strains of Streptococcus pneumoniae by cefotaxime, ceftriaxone, and ceftizoxime: a comparison of bactericidal and inhibitory activity with achievable CSF levels.
    Stratton CW; Aldridge KE; Gelfand MS
    Diagn Microbiol Infect Dis; 1995; 22(1-2):35-42. PubMed ID: 7587048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of penicillin and three third-generation cephalosporins against US isolates of Streptococcus pneumoniae: a 1995 surveillance study.
    Thornsberry C; Burton PH; Vanderhoof BH
    Diagn Microbiol Infect Dis; 1996 Jun; 25(2):89-95. PubMed ID: 8882895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diminished activity of ceftizoxime in comparison to cefotaxime and ceftriaxone against Streptococcus pneumoniae.
    Haas DW; Stratton CW; Griffin JP; Weeks L; Alls SC
    Clin Infect Dis; 1995 Mar; 20(3):671-6. PubMed ID: 7756494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surrogate disks for predicting cefotaxime and ceftriaxone susceptibilities of Streptococcus pneumoniae.
    Barry AL; Fuchs PC
    J Clin Microbiol; 1996 Oct; 34(10):2609-12. PubMed ID: 8880533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences between ceftriaxone and cefotaxime: microbiological inconsistencies.
    Gums JG; Boatwright DW; Camblin M; Halstead DC; Jones ME; Sanderson R
    Ann Pharmacother; 2008 Jan; 42(1):71-9. PubMed ID: 18094350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of three commercial MIC systems, E test, fastidious antimicrobial susceptibility panel, and FOX fastidious panel, for confirmation of penicillin and cephalosporin resistance in Streptococcus pneumoniae.
    Krisher KK; Linscott A
    J Clin Microbiol; 1994 Sep; 32(9):2242-5. PubMed ID: 7814553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methods for predicting susceptibility of Streptococcus pneumoniae to cefixime.
    Barry AL; Fuchs PC
    J Clin Microbiol; 1995 Apr; 33(4):1031-3. PubMed ID: 7790431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activities of broad-spectrum cephalosporins against nonmeningeal isolates of Streptococcus pneumoniae: MIC interpretation using NCCLS M100-S12 recommendations.
    Sahm DF; Thornsberry C; Mayfield DC; Jones ME; Karlowsky JA
    J Clin Microbiol; 2002 Feb; 40(2):669-74. PubMed ID: 11825993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical isolates of Streptococcus pneumoniae with different susceptibilities to ceftriaxone and cefotaxime.
    Karlowsky JA; Jones ME; Draghi DC; Sahm DF
    Antimicrob Agents Chemother; 2003 Oct; 47(10):3155-60. PubMed ID: 14506024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of penicillin/amoxicillin non-susceptibility on the activity of third-generation cephalosporins against Streptococcus pneumoniae.
    Fenoll A; Giménez MJ; Robledo O; Aguilar L; Tarragó D; Granizo JJ; Martín-Herrero JE
    Eur J Clin Microbiol Infect Dis; 2008 Jan; 27(1):75-80. PubMed ID: 17943330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular epidemiology of penicillin-resistant Streptococcus pneumoniae isolated in central Taiwan.
    Liu PY; Hu BS; Fung CP; Lau YJ; Shi ZY; Lin YH
    Diagn Microbiol Infect Dis; 1998 Aug; 31(4):511-5. PubMed ID: 9764388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of invasive infections outside the central nervous system caused by Streptococcus pneumoniae isolates nonsusceptible to ceftriazone in children treated with beta-lactam antibiotics.
    Kaplan SL; Mason EO; Barson WJ; Tan TQ; Schutze GE; Bradley JS; Givner LB; Kim KS; Yogev R; Wald ER
    Pediatr Infect Dis J; 2001 Apr; 20(4):392-6. PubMed ID: 11332663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antibiotic resistance analysis of
    Ge LL; Han ZY; Liu AH; Zhu L; Meng JH
    Zhonghua Er Ke Za Zhi; 2017 Feb; 55(2):109-114. PubMed ID: 28173648
    [No Abstract]   [Full Text] [Related]  

  • 18. Streptococcus pneumoniae susceptible to benzylpenicillin but with reduced susceptibility to both cefotaxime and ceftriaxone.
    Bell SM; Gatus BJ; Pham JN
    Med J Aust; 1996 Feb; 164(3):188. PubMed ID: 8628145
    [No Abstract]   [Full Text] [Related]  

  • 19. In-vitro activity of 21 beta-lactam antibiotics against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
    Verhaegen J; Verbist L
    J Antimicrob Chemother; 1998 Mar; 41(3):381-5. PubMed ID: 9578165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antimicrobial resistance of Streptococcus pneumoniae, 2003-2009].
    Năstase E; Dorneanu O; Dorobăţ C
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(2):536-41. PubMed ID: 21870753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.